|
Symbol
|
OCJRCH | KAJDEU | RMBE7V | RSDACV | OVCRCH | Z09YJZ | ABVHSQ | PBURCH | RMA3QV | PEIRCH | Z0ARNZ | Z0ATYZ | Z0ATQZ | Z0AUCZ | RMBVBV | ADOJTQ | LZJRCH | LZQRCH | QXPRCH | RMAKZV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Worst of Callable Reverse Convertible | GOAL | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | ZKB Reverse Convertible on worst of Last Look | Multi Vonti | Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Kühne & Nagel Intl. AG / Lonza Group N / Sandoz Group AG | Julius Baer Group / Sandoz Group AG / Sika AG | Alcon / Sandoz Group AG | Sandoz Group AG | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Sandoz Group AG / VAT Group | Baloise N / Sandoz Group AG / Sika AG / Straumann Hldg. AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Lonza Group N / Novartis AG / Roche AG / Sandoz | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Alcon / Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Sandoz Group AG / Swissquote Group Hldg. S.A. / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Helvetia Hldg. AG / Sandoz Group AG | ABB / Compagnie Financière Richemont SA / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG | Givaudan / Novartis AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
08.04.2026 | 06.07.2026 | 13.07.2026 | 30.12.2025 | 09.06.2026 | 02.03.2026 | 07.10.2026 | 21.07.2026 | 09.11.2026 | 11.11.2026 | 25.08.2026 | 05.03.2027 | 07.09.2026 | 10.03.2026 | 13.03.2026 | 23.07.2026 | 24.07.2026 | 07.08.2029 | 25.08.2027 | 01.09.2028 |
| Ratio | - | - | - | 0,006458 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
192,6425 | 33,51 | 26,76 | 32,29 | 94,0875 | 337,029 | 22,8865 | 26,509 | 56,14 | 191,17 | 33,0638 | 75,9837 | 251,269 | 35,676 | 141,264 | 124,334 | 33,6975 | 2 627,25 | 35,955 | 37,68 |
| rendement max. p.a. | 48,42% | 23,77% | 13,11% | - | 23,12% | 8,15% | 25,99% | 7,20% | 7,30% | 4,47% | 6,13% | 18,27% | 46,72% | 34,67% | - | 7,78% | 12,10% | 4,89% | 6,77% | - |
| Demande | - | 91,70 | 95,30 | 100,40 | - | - | 84,97 | - | 97,30 | 99,55 | - | - | - | 109,68 | 98,20 | 101,77 | - | - | - | 95,10 |
| Offre | - | 92,70 | 98,30 | 101,00 | - | - | 85,77 | - | 100,30 | 100,35 | - | - | - | 110,43 | 99,00 | 102,59 | - | - | - | 96,10 |